Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/10/2014US20140099379 Bio-compatible nano and microparticles coated with stabilizers for pulmonary application
04/10/2014US20140099378 Modified Release Formulations of Anti-Irritability Drugs
04/10/2014US20140099377 Continuous method for producing nanoparticles and nanoparticles obtained by means of said method
04/10/2014US20140099376 Sequestered antagonist formulations
04/10/2014US20140099375 Methods of therapeutic treatment of eyes
04/10/2014US20140099370 Controlled release of biologically active compounds
04/10/2014US20140099369 Tamper-resistant oral opioid agonist formulations
04/10/2014US20140099368 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
04/10/2014US20140099367 Use of spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis
04/10/2014US20140099366 Composition Containing Two Anti-Dementia Drugs
04/10/2014US20140099364 Controlled release pharmaceutical compositions comprising a fumaric acid ester
04/10/2014US20140099362 Natural combination hormone replacement formulations and therapies
04/10/2014US20140099361 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
04/10/2014US20140099357 Biologically Efficacious Compositions, Articles of Manufacture and Processes for Producing and/or Using Same
04/10/2014US20140099356 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
04/10/2014US20140099354 Biopassivating membrane stabilization by means of nitrocarboxylic acid-containing phospholipids in preparations and coatings
04/10/2014US20140099352 Compositions, Structures and Methods for Neural Regeneration
04/10/2014US20140099345 Omega-3 Diglyceride Emulsions
04/10/2014US20140099336 Methods for Treating Dependence
04/10/2014US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
04/10/2014US20140099331 Zwitterionic immunomodulators for the teatment of asthma and allergy
04/10/2014US20140099323 Methods for treatment of inflammatory diseases
04/10/2014US20140099319 Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
04/10/2014US20140099316 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
04/10/2014US20140099300 Methods for predicting and improving the survival of gastric cancer patients
04/10/2014US20140099283 2'-chloro nucleoside analogs for hcv infection
04/10/2014US20140099281 Methods of treatment using an aminosterol composition
04/10/2014US20140099279 Metal alloys for medical devices
04/10/2014US20140099277 Biodegradable polyurethane/urea compositions
04/10/2014US20140099269 Chewing gum having sustained release of nicotine
04/10/2014US20140099268 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
04/10/2014US20140097114 Liquid pharmaceutical formulations of palonosetron
04/10/2014DE102013110890A1 Verwendung von Enalaprilat zur Behandlung Neurodegenerativer Krankheiten Use of enalaprilat treatment for neurodegenerative diseases
04/10/2014DE102013000700A1 Composition useful e.g. for treating inflammatory diseases of oral and pharyngeal cavity, comprises virustatic and/or antiviral polysaccharide, surface disinfectant, optionally acidic glycosaminoglycan and optionally local anesthetic
04/10/2014DE102013000699A1 Pharmaceutical composition, useful for topical treatment of hoarseness/inflammatory diseases of mouth and throat, comprises virustatisches or antiviral polysaccharide, and acidic glycosaminoglycan, preferably hyaluronic acid
04/09/2014EP2716769A2 Method of screening antipsychotic drugs
04/09/2014EP2716758A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION
04/09/2014EP2716659A1 Immunoassays for meperidine and metabolites
04/09/2014EP2716648A1 Isoxazolidine derivatives
04/09/2014EP2716647A2 Macrocyclic compounds and methods of making and using the same
04/09/2014EP2716643A1 Pyrrolopyrimidine compounds and their uses
04/09/2014EP2716642A1 Imidazopyridine compound
04/09/2014EP2716640A1 Hexahydrodibenzo[a,g]quinolizine compound, preparation method therefor, pharmaceutical composition and use thereof
04/09/2014EP2716639A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/09/2014EP2716638A1 Labeled ligands of the oxytocyn receptor
04/09/2014EP2716637A1 Mangiferin aglycone crystal form i and preparation method thereof
04/09/2014EP2716636A1 Cyclic amide derivative
04/09/2014EP2716635A1 Compounds which selectively modulate the CB2 receptor
04/09/2014EP2716633A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
04/09/2014EP2716632A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/09/2014EP2716626A1 Benzylamine derivative
04/09/2014EP2716304A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
04/09/2014EP2716303A1 Psychic energizer agent and psychic energizer composition
04/09/2014EP2716302A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
04/09/2014EP2716297A1 Activity enhancer for anticancer agent
04/09/2014EP2716293A1 Anti-tumor agent
04/09/2014EP2716292A1 Cdc42 inhibitor and uses thereof
04/09/2014EP2716291A1 Combination of opioids and anticancer drugs for cancer treatment
04/09/2014EP2716290A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
04/09/2014EP2716289A1 Wound and mucous membrane antiseptic based on Bispyridiniumalkanes
04/09/2014EP2716288A1 A method for decreasing symptoms of alcohol consumption
04/09/2014EP2716287A1 Ropinirole-containing adhesive skin patch and packaged product thereof
04/09/2014EP2716286A1 Ropinirole-containing adhesive patch and packaging therefor
04/09/2014EP2716285A2 New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
04/09/2014EP2716281A1 Method for producing powder for inhalation
04/09/2014EP2716279A1 Oral solutions containing leukotriene antagonists
04/09/2014EP2716158A1 Substituted triazolo-pyridazine derivatives
04/09/2014EP2716157A1 Imidazopyrazine Syk inhibitors
04/09/2014EP2716152A1 Gene associated with non-biological stress resistance, and transformed plant
04/09/2014EP2714905A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
04/09/2014EP2714904A2 Oligonucleotides for modulation of target rna activity
04/09/2014EP2714903A1 Suv39h2 as a target gene for cancer therapy and diagnosis
04/09/2014EP2714716A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
04/09/2014EP2714715A1 Pharmaceutical compositions
04/09/2014EP2714712A1 Process for the production of estetrol intermediates
04/09/2014EP2714710A1 Process for the production of estetrol intermediates
04/09/2014EP2714706A1 Sucrose octasulfates of calcium, preparation method thereof and pharmaceutical and cosmetic uses of same
04/09/2014EP2714705A1 Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical and cosmetic uses of same
04/09/2014EP2714703A1 Tricyclic inhibitors of poly(adp-ribose)polymerase
04/09/2014EP2714697A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
04/09/2014EP2714693A2 Anti-viral compounds
04/09/2014EP2714692A1 Substituted aminoimidazopyridazines
04/09/2014EP2714690A1 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
04/09/2014EP2714689A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
04/09/2014EP2714688A1 Heterocyclic compounds as protein kinase inhibitors
04/09/2014EP2714686A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
04/09/2014EP2714685A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014EP2714684A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014EP2714683A2 Amorphous ritonavir co-precipitated
04/09/2014EP2714682A1 Novel tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases
04/09/2014EP2714681A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
04/09/2014EP2714680A1 Heterocyclic autotaxin inhibitors and uses thereof
04/09/2014EP2714679A1 Novel imidazole derivatives useful for the treatment of arthritis
04/09/2014EP2714678A1 Imidazole derivatives
04/09/2014EP2714677A1 Pyridine-and pyrazine derivatives
04/09/2014EP2714675A1 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use
04/09/2014EP2714668A1 Thiazole derivatives
04/09/2014EP2714667A2 Aminooxazole inhibitors of cyclin dependent kinases
04/09/2014EP2714665A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
04/09/2014EP2714662A1 Neprilysin inhibitors
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 7860